Meisel, Andreas
Smith, Craig J.
Article History
First Online: 3 November 2015
Competing interests
: A.M. receives funding from Thermo Fisher Scientific, and also has patent EP1480646 issued for anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident. C.J.S. declares no competing interests.